Browse by UCL people
Group by: Type | Date
Number of items: 134.
Article
Akhtar, S;
Grizenkova, J;
Wenborn, A;
Hummerich, H;
Fernandez de Marco, M;
Brandner, S;
Collinge, J;
(2013)
Sod1 deficiency reduces incubation time in mouse models of prion disease.
PLoS One
, 8
(1)
, Article e54454. 10.1371/journal.pone.0054454.
|
Akhtar, S;
Wenborn, A;
Brandner, S;
Collinge, J;
Lloyd, SE;
(2011)
Sex effects in mouse prion disease incubation time.
PLOS One
, 6
(12)
, Article e28741. 10.1371/journal.pone.0028741.
|
Asante, EA;
Grimshaw, A;
Smidak, M;
Jakubcova, T;
Tomlinson, A;
Jeelani, A;
Hamdan, S;
... Collinge, J; + view all
(2015)
Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS.
PLOS Pathogens
, 11
(7)
, Article e1004953. 10.1371/journal.ppat.1004953.
|
Asante, EA;
Linehan, JM;
Smidak, M;
Tomlinson, A;
Grimshaw, A;
Jeelani, A;
Jakubcova, T;
... Collinge, J; + view all
(2013)
Inherited Prion Disease A117V Is Not Simply a Proteinopathy but Produces Prions Transmissible to Transgenic Mice Expressing Homologous Prion Protein.
PLoS Pathog
, 9
(9)
, Article e1003643. 10.1371/journal.ppat.1003643.
|
Asante, EA;
Linehan, JM;
Tomlinson, AD;
Jakubcova, T;
Hamdan, S;
Grimshaw, A;
Smidak, M;
... Collinge, J; + view all
(2020)
Spontaneous generation of prions and transmissible PrP amyloid in a humanised transgenic mouse model of A117V GSS.
PLOS Biology
, 18
(6)
, Article e3000725. 10.1371/journal.pbio.3000725.
|
Asante, EA;
Smidak, M;
Grimshaw, A;
Houghton, R;
Tomlinson, A;
Jeelani, A;
Jakubcova, T;
... Collinge, J; + view all
(2015)
A naturally occurring variant of the human prion protein completely prevents prion disease.
Nature
, 522
pp. 478-481.
10.1038/nature14510.
|
Balendra, R;
Uphill, J;
Collinson, C;
Druyeh, R;
Adamson, G;
Hummerich, H;
Zerr, I;
... Mead, S; + view all
(2016)
Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international study.
BMC Medical Genetics
, 17
, Article 28. 10.1186/s12881-016-0278-2.
|
Banerjee, G;
Farmer, SF;
Hyare, H;
Jaunmuktane, Z;
Mead, S;
Ryan, NS;
Schott, JM;
... Collinge, J; + view all
(2024)
Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone.
Nature Medicine
10.1038/s41591-023-02729-2.
(In press).
|
Benilova, I;
Reilly, M;
Terry, C;
Wenborn, A;
Schmidt, C;
Marinho, AT;
Risse, E;
... Collinge, J; + view all
(2020)
Highly infectious prions are not directly neurotoxic.
Proceeding of the National Academy of Sciences of the United States of America
10.1073/pnas.2007406117.
(In press).
|
Bonham, LW;
Karch, CM;
Fan, CC;
Tan, C;
Geier, EG;
Wang, Y;
Wen, N;
... International Genomics of Alzheimer’s Project (IGAP); + view all
(2018)
CXCR4 involvement in neurodegenerative diseases.
Translational Psychiatry
, 8
(1)
, Article 73. 10.1038/s41398-017-0049-7.
|
Bonham, LW;
Steele, NZR;
Karch, CM;
Broce, I;
Geier, EG;
Wen, NL;
Momeni, P;
... International FTD-Genomics Consortium (IFGC), .; + view all
(2019)
Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia.
Scientific Reports
, 9
, Article 10854. 10.1038/s41598-019-46415-1.
|
Broce, I;
Karch, CM;
Wen, N;
Fan, CC;
Wang, Y;
Tan, CH;
Kouri, N;
... Sugrue, LP; + view all
(2018)
Immune-related genetic enrichment in frontotemporal dementia: An analysis of genome-wide association studies.
PLoS Medicine
, 15
(1)
, Article e1002487. 10.1371/journal.pmed.1002487.
|
Brown, CA;
Schmidt, C;
Poulter, M;
Hummerich, H;
Klöhn, PC;
Jat, P;
Mead, S;
... Lloyd, SE; + view all
(2014)
In-vitro screen of prion disease susceptibility genes using the scrapie cell assay.
Hum Mol Genet
, 23
(19)
pp. 5102-5108.
10.1093/hmg/ddu233.
|
C Dabin, L;
Guntoro, F;
Campbell, T;
Bélicard, T;
Smith, AR;
Smith, RG;
Raybould, R;
... Viré, E; + view all
(2020)
Altered DNA methylation profiles in blood from patients with sporadic Creutzfeldt–Jakob disease.
Acta Neuropathologica
10.1007/s00401-020-02224-9.
(In press).
|
Caine, D;
Nihat, A;
Crabb, P;
Rudge, P;
Cipolotti, L;
Collinge, J;
Mead, S;
(2018)
The language disorder of prion disease is characteristic of a dynamic aphasia and is rarely an isolated clinical feature.
PLoS One
, 13
(1)
, Article e0190818. 10.1371/journal.pone.0190818.
|
Caine, D;
Tinelli, RJ;
Hyare, H;
De Vita, E;
Lowe, J;
Lukic, A;
Thompson, A;
... Mead, S; + view all
(2015)
The cognitive profile of prion disease: a prospective clinical and imaging study.
Ann Clin Transl Neurol
, 2
(5)
pp. 548-558.
10.1002/acn3.195.
|
Canas, LS;
Sudre, CH;
De Vita, E;
Nihat, A;
Mok, TH;
Slattery, CF;
Paterson, RW;
... Modat, M; + view all
(2019)
Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.
NeuroImage: Clinical
, Article 102051. 10.1016/j.nicl.2019.102051.
(In press).
|
Castro-Seoane, R;
Hummerich, H;
Sweeting, T;
Tattum, MH;
Linehan, JM;
Fernandez de Marco, M;
Brandner, S;
... Klöhn, PC; + view all
(2012)
Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.
PLoS Pathogens
, 8
(2)
, Article e1002538. 10.1371/journal.ppat.1002538.
|
Chia, R;
Tattum, MH;
Jones, S;
Collinge, J;
Fisher, EMC;
Jackson, GS;
(2010)
Superoxide Dismutase 1 and tgSOD1(G93A) Mouse Spinal Cord Seed Fibrils, Suggesting a Propagative Cell Death Mechanism in Amyotrophic Lateral Sclerosis.
PLOS ONE
, 5
(5)
, Article e10627. 10.1371/journal.pone.0010627.
|
Clayton, EL;
Mancuso, R;
Nielsen, TT;
Mizielinska, S;
Holmes, H;
Powell, N;
Norona, F;
... Isaacs, AM; + view all
(2017)
Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation.
Human Molecular Genetics
, 26
(5)
pp. 873-887.
10.1093/hmg/ddx003.
|
Clayton, EL;
Milioto, C;
Muralidharan, B;
Norona, FE;
Edgar, JR;
Soriano, A;
Jafar-Nejad, P;
... Isaacs, AM; + view all
(2018)
Frontotemporal dementia causative CHMP2B impairs neuronal endolysosomal traffic-rescue by TMEM106B knockdown.
Brain
, 141
(12)
pp. 3428-3442.
10.1093/brain/awy284.
|
Clayton, EL;
Mizielinska, S;
Edgar, JR;
Nielsen, TT;
Marshall, S;
Norona, FE;
Robbins, M;
... Isaacs, AM; + view all
(2015)
Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.
Acta Neuropathologica
, 130
(4)
pp. 511-523.
10.1007/s00401-015-1475-3.
|
Collinge, J;
Jaunmuktane, Z;
Mead, S;
Rudge, P;
Brandner, S;
(2016)
Collinge et al. reply.
[Rapid communication].
Nature
, 537
E7-E9.
10.1038/nature19087.
|
Collinge, J;
Jaunmuktane, Z;
Mead, S;
Rudge, P;
Brandner, S;
(2016)
Collinge et al. reply.
[Rapid communication].
Nature
, 535
E2-E3.
10.1038/nature18603.
|
Collinge, J;
Purro, SA;
Nicoll, A;
(2018)
Prion Protein as a Toxic Acceptor of Amyloid-β Oligomers.
Biological Psychiatry
, 83
(4)
pp. 358-368.
10.1016/j.biopsych.2017.11.020.
|
Corbett, GT;
Wang, Z;
Hong, W;
Colom-Cadena, M;
Rose, J;
Liao, M;
Asfaw, A;
... Walsh, DM; + view all
(2019)
PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.
Acta Neuropathologica
10.1007/s00401-019-02114-9.
(In press).
|
Corbie, Rosie;
Campbell, Tracy;
Darwent, Lee;
Rudge, Peter;
Collinge, John;
Mead, Simon;
(2022)
Estimation of the number of inherited prion disease mutation carriers in the UK.
European Journal of Human Genetics
10.1038/s41431-022-01132-8.
(In press).
|
D'Castro, L;
Wenborn, A;
Gros, N;
Joiner, S;
Cronier, S;
Collinge, J;
Wadsworth, JDF;
(2010)
Isolation of Proteinase K-Sensitive Prions Using Pronase E and Phosphotungstic Acid.
PLOS ONE
, 5
(12)
, Article e15679. 10.1371/journal.pone.0015679.
|
De Vita, E;
Ridgway, GR;
White, MJ;
Porter, MC;
Caine, D;
Rudge, P;
Collinge, J;
... Hyare, H; + view all
(2017)
Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.
NeuroImage: Clinical
, 13
pp. 89-96.
10.1016/j.nicl.2016.10.021.
|
Eisenmenger, L;
Porter, MC;
Carswell, CJ;
Thompson, A;
Mead, S;
Rudge, P;
Collinge, J;
... Hyare, H; + view all
(2016)
Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.
JAMA Neurology
, 73
(1)
pp. 76-84.
10.1001/jamaneurol.2015.3159.
|
Escott-Price, V;
Bellenguez, C;
Wang, LS;
Choi, SH;
Harold, D;
Jones, L;
Holmans, P;
... Cardiovascular Health Study (CHS); + view all
(2014)
Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.
PLoS One
, 9
(6)
, Article e94661. 10.1371/journal.pone.0094661.
|
Ferrari, R;
Wang, Y;
Vandrovcova, J;
Guelfi, S;
Witeolar, A;
Karch, CM;
Schork, AJ;
... Desikan, RS; + view all
(2017)
Genetic architecture of sporadic frontotemporal dementia and overlap with Alzheimer's and Parkinson's diseases.
Journal of Neurology, Neurosurgery and Psychiatry
, 88
(2)
pp. 152-164.
10.1136/jnnp-2016-314411.
|
Ford, L;
Rudge, P;
Robinson, K;
Collinge, J;
Gorham, M;
Mead, S;
(2019)
The most problematic symptoms of prion disease - an analysis of carer experiences.
International Psychogeriatrics
, 31
(8)
pp. 1181-1190.
10.1017/S1041610218001588.
|
Franko, E;
Wehner, T;
Joly, O;
Lowe, J;
Porter, MC;
Kenny, J;
Thompson, A;
... Mead, S; + view all
(2016)
Quantitative EEG parameters correlate with the progression of human prion diseases.
Journal of Neurology, Neurosurgery & Psychiatry
, 87
(10)
pp. 1061-1067.
10.1136/jnnp-2016-313501.
|
Fratta, P;
Poulter, M;
Lashley, T;
Rohrer, JD;
Polke, JM;
Beck, J;
Ryan, N;
... Mead, S; + view all
(2013)
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia.
Acta Neuropathologica
, 126
(3)
pp. 401-409.
10.1007/s00401-013-1147-0.
|
Freir, DB;
Nicoll, AJ;
Klyubin, I;
Panico, S;
Mc Donald, JM;
Risse, E;
Asante, EA;
... Collinge, J; + view all
(2011)
Interaction between prion protein and toxic amyloid beta assemblies can be therapeutically targeted at multiple sites.
Nature Communications
, 2
, Article 336. 10.1038/ncomms1341.
|
Gao, Y;
Wang, T;
Yu, X;
International FTD-Genomics Consortium (IFGC);
Zhao, H;
Zeng, P;
(2020)
Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis.
Scientific Reports
, 10
, Article 12184. 10.1038/s41598-020-68848-9.
|
Ge, YJ;
Ou, YN;
Deng, YT;
Wu, BS;
Yang, L;
Zhang, YR;
Chen, SD;
... Sorbi, S; + view all
(2023)
Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
Biological Psychiatry
, 93
(9)
pp. 770-779.
10.1016/j.biopsych.2022.11.002.
|
Ghosh, U;
Yau, W-M;
Collinge, J;
Tycko, R;
(2021)
Structural differences in amyloid-β fibrils from brains of non-demented elderly individuals and Alzheimer's disease patients.
Proceedings of the National Academy of Sciences of the United States of America (PNAS)
, 118
(45)
, Article e2111863118. 10.1073/pnas.2111863118.
|
Grizenkova, J;
Akhtar, S;
Brandner, S;
Collinge, J;
Lloyd, SE;
(2014)
Microglial Cx3cr1 knockout reduces prion disease incubation time in mice.
BMC Neurosci
, 15
, Article 44. 10.1186/1471-2202-15-44.
|
Grizenkova, J;
Akhtar, S;
Collinge, J;
Lloyd, SE;
(2010)
The Retinoic Acid Receptor Beta (Rarb) Region of Mmu14 Is Associated with Prion Disease Incubation Time in Mouse.
PLOS ONE
, 5
(12)
, Article e15019. 10.1371/journal.pone.0015019.
|
Guerreiro, RJ;
Beck, J;
Gibbs, JR;
Santana, I;
Rossor, MN;
Schott, JM;
Nalls, MA;
... Hardy, J; + view all
(2010)
Genetic Variability in CLU and Its Association with Alzheimer's Disease.
PLOS ONE
, 5
(3)
, Article e9510. 10.1371/journal.pone.0009510.
|
Hassan, A;
Campbell, T;
Darwent, L;
Odd, H;
Green, A;
Collinge, J;
Mead, S;
(2021)
Case report of homozygous E200D mutation of PRNP in apparently sporadic Creutzfeldt-Jakob disease.
BMC Neurology
, 21
, Article 248. 10.1186/s12883-021-02274-w.
|
Hosszu, LLP;
Conners, R;
Sangar, D;
Batchelor, M;
Sawyer, EB;
Fisher, S;
Cliff, MJ;
... Collinge, J; + view all
(2020)
Structural effects of the highly protective V127 polymorphism on human prion protein.
Communications Biology
, 3
(1)
, Article 402. 10.1038/s42003-020-01126-6.
|
Hu, NW;
Nicoll, AJ;
Zhang, D;
Mably, AJ;
O'Malley, T;
Purro, SA;
Terry, C;
... Rowan, MJ; + view all
(2014)
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.
Nature Communications
, 5
, Article 3374. 10.1038/ncomms4374.
|
Hyare, H;
De Vita, E;
Porter, M-C;
Simpson, I;
Ridgway, G;
Lowe, J;
Thompson, A;
... Thornton, JS; + view all
(2020)
Putaminal diffusion tensor imaging measures predict disease severity across human prion diseases.
Brain Communications
, 2
(1)
, Article fcaa032. 10.1093/braincomms/fcaa032.
|
Jackson, Graham S;
Linehan, Jacqueline;
Brandner, Sebastian;
Asante, Emmanuel A;
Wadsworth, Jonathan DF;
Collinge, John;
(2022)
Overexpression of mouse prion protein in transgenic mice causes a non-transmissible spongiform encephalopathy.
Scientific Reports
, 12
, Article 17198. 10.1038/s41598-022-21608-3.
|
Jesuthasan, Aaron;
Sequeira, Danielle;
Hyare, Harpreet;
Odd, Hans;
Rudge, Peter;
Mok, Tze How;
Nihat, Akin;
... Mead, Simon; + view all
(2022)
Assessing initial MRI reports for suspected CJD patients.
Journal of Neurology
10.1007/s00415-022-11087-x.
(In press).
|
Joiner, S;
Asante, EA;
Linehan, JM;
Brock, L;
Brandner, S;
Bellworthy, SJ;
Simmons, MM;
... Wadsworth, JDF; + view all
(2018)
Experimental sheep BSE prions generate the vCJD phenotype when serially passaged in transgenic mice expressing human prion protein.
Journal of the Neurological Sciences
, 386
pp. 4-11.
10.1016/j.jns.2017.12.038.
|
Jones, E;
Hummerich, H;
Viré, E;
Uphill, J;
Dimitriadis, A;
Speedy, H;
Campbell, T;
... Mead, S; + view all
(2020)
Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study.
The Lancet Neurology
, 19
(10)
pp. 840-848.
10.1016/S1474-4422(20)30273-8.
|
Jones, L;
Holmans, PA;
Hamshere, ML;
Harold, D;
Moskvina, V;
Ivanov, D;
Pocklington, A;
... Williams, J; + view all
(2011)
Correction: genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease.
PLoS One
, 6
(2)
, Article e13950. 10.1371/journal.pone.0013950.
|
Jones, L;
Holmans, PA;
Hamshere, ML;
Harold, D;
Moskvina, V;
Ivanov, D;
Pocklington, A;
... Williams, J; + view all
(2010)
Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease.
PLOS ONE
, 5
(11)
, Article e13950. 10.1371/journal.pone.0013950.
|
Katrak, S;
Pauranik, A;
Desai, S;
Mead, S;
Beck, J;
Brandner, S;
Collinge, J;
(2019)
Familial Creutzfeldt-Jakob disease in an Indian kindred.
Annals of Indian Academy of Neurology
, 22
(4)
pp. 458-461.
10.4103/aian.AIAN_214_19.
|
Kenny, J;
Woollacott, I;
Koriath, C;
Hosszu, L;
Adamson, G;
Rudge, P;
Rossor, MN;
... Mead, S; + view all
(2017)
A novel prion protein variant in a patient with semantic dementia.
[Letter].
Journal of Neurology Neurosurgery and Psychiatry
, 2017
(88)
pp. 890-892.
10.1136/jnnp-2017-315577.
|
Klyubin, I;
Nicoll, AJ;
Khalili-Shirazi, A;
Farmer, M;
Canning, S;
Mably, A;
Linehan, J;
... Collinge, J; + view all
(2014)
Peripheral Administration of a Humanized Anti-PrP Antibody Blocks Alzheimer's Disease Aβ Synaptotoxicity.
J Neurosci
, 34
(18)
6140 - 6145.
10.1523/JNEUROSCI.3526-13.2014.
|
Koriath, C;
(2018)
Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series.
Molecular Psychiatry
10.1038/s41380-018-0224-0.
(In press).
|
Koriath, C;
Lashley, T;
Taylor, W;
Druyeh, R;
Dimitriadis, A;
Denning, N;
Williams, J;
... Mead, S; + view all
(2019)
ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 277-280.
10.1016/j.dadm.2019.01.010.
|
Kotta, K;
Paspaltsis, I;
Bostantjopoulou, S;
Latsoudis, H;
Plaitakis, A;
Kazis, D;
Collinge, J;
(2006)
Novel mutation of the PRNP gene of a clinical CJD case.
BMC Infectious Diseases
, 6
, Article 169. 10.1186/1471-2334-6-169.
|
Kunkle, BW;
Grenier-Boley, B;
Sims, R;
Bis, JC;
Damotte, V;
Naj, AC;
Boland, A;
... Pericak-Vance, MA; + view all
(2019)
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing.
Nature Genetics
, 51
pp. 414-430.
10.1038/s41588-019-0358-2.
|
L P Hosszu, Laszlo;
Sangar, Daljit;
Batchelor, Mark;
Risse, Emmanuel;
Hounslow, Andrea M;
Collinge, John;
Waltho, Jonathan P;
(2023)
Loss of residues 119 – 136, including the first β-strand of human prion protein, generates an aggregation-competent partially “open” form.
Journal of Molecular Biology
, Article 168158. 10.1016/j.jmb.2023.168158.
(In press).
|
Lauwers, E;
Lalli, G;
Brandner, S;
Collinge, J;
Compernolle, V;
Duyckaerts, C;
Edgren, G;
... De Strooper, B; + view all
(2020)
Potential human transmission of amyloid β pathology: surveillance and risks.
The Lancet Neurology
, 19
(10)
pp. 872-878.
10.1016/S1474-4422(20)30238-6.
|
Leonenko, G;
Sims, R;
Shoai, M;
Frizzati, A;
Bossu, P;
Spalletta, G;
Fox, NC;
... Munger, R; + view all
(2019)
Polygenic risk and hazard scores for Alzheimer's disease prediction.
Annals of Clinical and Translational Neurology
, 6
(3)
pp. 456-465.
10.1002/acn3.716.
|
Lloyd, SE;
Maytham, EG;
Pota, H;
Grizenkova, J;
Molou, E;
Uphill, J;
Hummerich, H;
... Collinge, J; + view all
(2009)
HECTD2 Is Associated with Susceptibility to Mouse and Human Prion Disease.
PLOS GENET
, 5
(2)
, Article e1000383. 10.1371/journal.pgen.1000383.
|
Lloyd, SE;
Rossor, M;
Fox, N;
Mead, S;
Collinge, J;
(2009)
HECTD2, a candidate susceptibility gene for Alzheimer's disease on 10q.
BMC Medical Genetics
, 10
, Article 90. 10.1186/1471-2350-10-90.
|
Luk, C;
Jones, S;
Thomas, C;
Fox, NC;
Mok, TH;
Mead, S;
Collinge, J;
(2016)
Diagnosing Sporadic Creutzfeldt-Jakob Disease by the Detection of Abnormal Prion Protein in Patient Urine.
JAMA Neurology
, 73
(12)
pp. 1454-1460.
10.1001/jamaneurol.2016.3733.
|
Mahoney, CJ;
Beck, J;
Rohrer, JD;
Lashley, T;
Mok, K;
Shakespeare, T;
Yeatman, T;
... Warren, JD; + view all
(2012)
Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.
Brain
, 135
(3)
736 - 750.
10.1093/brain/awr361.
|
Majounie, E;
Renton, AE;
Mok, K;
Dopper, EG;
Waite, A;
Rollinson, S;
Chiò, A;
... Traynor, BJ; + view all
(2012)
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study.
Lancet Neurology
, 11
(4)
323 - 330.
10.1016/S1474-4422(12)70043-1.
|
Manka, Szymon W;
Wenborn, Adam;
Collinge, John;
Wadsworth, Jonathan DF;
(2022)
Prion strains viewed through the lens of cryo-EM.
Cell and Tissue Research
10.1007/s00441-022-03676-z.
(In press).
|
Manka, Szymon W;
Zhang, Wenjuan;
Wenborn, Adam;
Betts, Jemma;
Joiner, Susan;
Saibil, Helen R;
Collinge, John;
(2022)
2.7 Å cryo-EM structure of ex vivo RML prion fibrils.
Nat Commun
, 13
, Article 4004. 10.1038/s41467-022-30457-7.
|
Marbiah, MM;
Harvey, A;
West, BT;
Louzolo, A;
Banerjee, P;
Alden, J;
Grigoriadis, A;
... Klöhn, PC; + view all
(2014)
Identification of a gene regulatory network associated with prion replication.
The EMBO Journal
, 33
(14)
1503- 1614.
10.15252/embj.201387150.
|
McKinnon, C;
Goold, R;
Andre, R;
Devoy, A;
Ortega, Z;
Moonga, J;
Linehan, JM;
... Tabrizi, SJ; + view all
(2016)
Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
Acta Neuropathologica
, 131
(3)
pp. 411-425.
10.1007/s00401-015-1508-y.
|
McNaughton, D;
Knight, W;
Guerreiro, R;
Ryan, N;
Lowe, J;
Poulter, M;
Nicholl, DJ;
... Mead, S; + view all
(2012)
Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series.
Neurobioly of Aging
, 33
(2)
426.e13 - 426.e21.
10.1016/j.neurobiolaging.2010.10.010.
|
McNiven, K;
Nihat, A;
Mok, TH;
Tesfamichael, S;
O’Donnell, V;
Rudge, P;
Collinge, J;
(2019)
Enteral feeding is associated with longer survival in the advanced stages of prion disease.
Brain Communications
, 1
(1)
, Article fcz012. 10.1093/braincomms/fcz012.
|
Mead, S;
Khalili-Shirazi, A;
Potter, C;
Mok, T;
Nihat, A;
Hyare, H;
Canning, S;
... Collinge, J; + view all
(2022)
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme.
The Lancet Neurology
, 21
(4)
pp. 342-354.
10.1016/S1474-4422(22)00082-5.
|
Mead, S;
Burnell, M;
Lowe, J;
Thompson, A;
Lukic, A;
Porter, MC;
Carswell, C;
... Collinge, J; + view all
(2016)
Clinical Trial Simulations Based on Genetic Stratification and the Natural History of a Functional Outcome Measure in Creutzfeldt-Jakob Disease.
JAMA Neurology
, 73
(4)
pp. 447-455.
10.1001/jamaneurol.2015.4885.
|
Mead, S;
Gandhi, S;
Beck, J;
Caine, D;
Gallujipali, D;
Carswell, C;
Hyare, H;
... Collinge, J; + view all
(2013)
A Novel Prion Disease Presenting with Diarrhea and Autonomic Neuropathy.
New England Journal of Medicine
, 369
(20)
1904- 1914.
10.1056/NEJMoa1214747.
|
|
Mead, S;
Lloyd, S;
Collinge, J;
(2019)
Genetic Factors in Mammalian Prion Diseases.
Annual Review of Genetics
, 53
, Article 21. 10.1146/annurev-genet-120213-092352.
(In press).
|
Mengel, D;
Mok, TH;
Nihat, A;
Liu, W;
Rissman, RA;
Galasko, D;
Zetterberg, H;
... Walsh, DM; + view all
(2021)
NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression.
Cells
, 10
(12)
, Article 3514. 10.3390/cells10123514.
|
Mengel, D;
Hong, W;
Corbett, GT;
Liu, W;
DeSousa, A;
Solforosi, L;
Fang, C;
... Walsh, DM; + view all
(2019)
PrP-grafted antibodies bind certain amyloid β-protein aggregates, but do not prevent toxicity.
Brain Research
, 1710
pp. 125-135.
10.1016/j.brainres.2018.12.038.
|
Mirabile, I;
Jat, PS;
Brandner, S;
Collinge, J;
(2015)
Identification of clinical target areas in the brainstem of prion-infected mice.
Neuropathology and Applied Neurobiology
, 41
(5)
pp. 613-630.
10.1111/nan.12189.
|
Mok, Tze How;
Nihat, Akin;
Majbour, Nour;
Sequeira, Danielle;
Holm-Mercer, Leah;
Coysh, Thomas;
Darwent, Lee;
... Mead, Simon; + view all
(2023)
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Brain
, Article awad101. 10.1093/brain/awad101.
|
Mok, T;
Jaunmuktane, Z;
Joiner, S;
Campbell, T;
Morgan, C;
Wakerley, B;
Golestani, F;
... Collinge, J; + view all
(2017)
Variant Creutzfeldt-Jakob Disease in a Patient with Heterozygosity at PRNP Codon 129.
The New England Journal of Medicine
, 376
(3)
pp. 292-294.
10.1056/NEJMc1610003.
|
Mok, TH;
Koriath, C;
Jaunmuktane, Z;
Campbell, T;
Joiner, S;
Wadsworth, JDF;
Hosszu, LLP;
... Mead, S; + view all
(2018)
Evaluating the causality of novel sequence variants in the prion protein gene by example.
Neurobiology of Aging
, 71
265.e1-265.e7.
10.1016/j.neurobiolaging.2018.05.011.
|
Mok, TH;
Nihat, A;
Luk, C;
Sequeira, D;
Batchelor, M;
Mead, S;
Collinge, J;
(2021)
Bank vole prion protein extends the use of RT-QuIC assays to detect prions in a range of inherited prion diseases.
Scientific Reports
, 11
(1)
, Article 5231. 10.1038/s41598-021-84527-9.
|
Mole, J;
Mead, S;
Rudge, P;
Nihat, A;
Mok, T;
Collinge, J;
Caine, D;
(2021)
Cognitive decline heralds onset of symptomatic inherited prion disease.
Brain
, 144
(3)
pp. 989-998.
10.1093/brain/awaa409.
|
Nahass, GR;
Sun, Y;
Xu, Y;
Batchelor, M;
Reilly, M;
Benilova, I;
Kedia, N;
... Bieschke, J; + view all
(2021)
Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium.
Journal of Molecular Biology
, 433
(8)
, Article 166878. 10.1016/j.jmb.2021.166878.
|
Nicoll, AJ;
Panico, S;
Freir, DB;
Wright, D;
Terry, C;
Risse, E;
Herron, CE;
... Collinge, J; + view all
(2013)
Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity.
Nature Communications
, 4
, Article 2416 . 10.1038/ncomms3416.
|
Nihat, A;
Mok, TH;
Odd, H;
Thompson, AGB;
Caine, D;
McNiven, K;
O'Donnell, V;
... Mead, S; + view all
(2022)
Development of novel clinical examination scales for the measurement of disease severity in Creutzfeldt-Jakob disease.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2021-327722.
(In press).
|
Norsworthy, PJ;
Thompson, AGB;
Mok, TH;
Guntoro, F;
Dabin, LC;
Nihat, A;
Paterson, RW;
... Viré, EA; + view all
(2020)
A blood miRNA signature associates with sporadic Creutzfeldt-Jakob disease diagnosis.
Nature Communications
, 11
(1)
, Article 3960. 10.1038/s41467-020-17655-x.
|
Owen, J;
Beck, J;
Campbell, T;
Adamson, G;
Gorham, M;
Thompson, A;
Smithson, S;
... Mead, S; + view all
(2014)
Predictive testing for inherited prion disease: report of 22 years experience.
European Journal of Human Genetics
, 22
(12)
pp. 1351-1356.
10.1038/ejhg.2014.42.
|
Peloso, GM;
van der Lee, SJ;
Sims, R;
van der Lee, SJ;
Naj, AC;
Bellenguez, C;
Badarinarayan, N;
... Crane, PK; + view all
(2018)
Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 10
pp. 595-598.
10.1016/j.dadm.2018.08.008.
|
Properzi, F;
Badhan, A;
Klier, S;
Schmidt, C;
Klohn, PC;
Wadsworth, JDF;
Clarke, AR;
... Collinge, J; + view all
(2016)
Physical, chemical and kinetic factors affecting prion infectivity.
Prion
, 10
(3)
pp. 251-261.
10.1080/19336896.2016.1181250.
|
Purro, SA;
Farrow, MA;
Linehan, J;
Nazari, T;
Thomas, DX;
Chen, Z;
Mengel, D;
... Collinge, J; + view all
(2018)
Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.
Nature
, 564
(7736)
pp. 415-419.
10.1038/s41586-018-0790-y.
|
Qiang, W;
Yau, W-M;
Lu, J-X;
Collinge, J;
Tycko, R;
(2017)
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Nature
, 541
(7636)
pp. 217-221.
10.1038/nature20814.
|
Quinn, L;
Whitfield, J;
Alpers, MP;
Campbell, T;
Hummerich, H;
Pomat, W;
Siba, P;
... Mead, S; + view all
(2024)
Population structure and migration in the Eastern Highlands of Papua New Guinea, a region impacted by the kuru epidemic.
American Journal of Human Genetics
, 111
(4)
pp. 668-679.
10.1016/j.ajhg.2024.02.011.
|
Reilly, Madeleine;
Benilova, Iryna;
Khalili-Shirazi, Azadeh;
Schmidt, Christian;
Ahmed, Parvin;
Yip, Daniel;
Jat, Parmjit S;
(2022)
A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody.
Scientific Reports
, 12
, Article 9493. 10.1038/s41598-022-13455-z.
|
Reus, LM;
Pasaniuc, B;
Posthuma, D;
Boltz, T;
Pijnenburg, YAL;
Ophoff, RA;
(2021)
Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes.
Biological Psychiatry
, 89
(8)
pp. 825-835.
10.1016/j.biopsych.2020.12.023.
|
Risse, E;
Nicoll, AJ;
Taylor, WA;
Wright, D;
Badoni, M;
Yang, X;
Farrow, MA;
(2015)
Identification of a Compound That Disrupts Binding of Amyloid-β to the Prion Protein Using a Novel Fluorescence-based Assay.
Journal of Biological Chemistry
, 290
(27)
pp. 17020-17028.
10.1074/jbc.M115.637124.
|
Roos, P;
Johannsen, P;
Lindquist, SG;
Brown, JM;
Waldemar, G;
Duno, M;
Nielsen, TT;
... Nielsen, JE; + view all
(2022)
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survival.
Acta Neurologica Scandinavica
, 145
(5)
pp. 529-540.
10.1111/ane.13578.
|
Rossi, M;
Mead, S;
Collinge, J;
Rudge, P;
Vincent, A;
(2015)
Neuronal antibodies in patients with suspected or confirmed sporadic Creutzfeldt-Jakob Disease.
Journal of Neurology, Neurosurgery, and Psychiatry
, 86
(6)
pp. 692-694.
10.1136/jnnp-2014-308695.
|
Rostgaard, N;
Roos, P;
Budtz-Jorgensen, E;
Johannsen, P;
Waldemar, G;
Norremolle, A;
Lindquist, SG;
... Nielsen, JE; + view all
(2017)
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3).
Neurobiology of Aging
, 59
221.e1-221.e7.
10.1016/j.neurobiolaging.2017.06.026.
|
Rudge, P;
Hyare, H;
Green, A;
Collinge, J;
Mead, S;
(2018)
Imaging and CSF analyses effectively distinguish CJD from its mimics.
Journal of Neurology, Neurosurgery, and Psychiatry
, 89
(5)
pp. 461-466.
10.1136/jnnp-2017-316853.
|
Rudge, P;
Jaunmuktane, Z;
Adlard, P;
Bjurstrom, N;
Caine, D;
Lowe, J;
Norsworthy, P;
... Collinge, J; + view all
(2015)
Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
Brain
, 138
(Pt 11)
pp. 3386-3399.
10.1093/brain/awv235.
|
Rudge, P;
Jaunmuktane, Z;
Hyare, H;
Ellis, M;
Koltzenburg, M;
Collinge, J;
Brandner, S;
(2019)
Early neurophysiological biomarkers and spinal cord pathology in inherited prion disease.
Brain
10.1093/brain/awy358.
(In press).
|
Sandberg, MK;
Al-Doujaily, H;
Sharps, B;
De Oliveira, MW;
Schmidt, C;
Richard-Londt, A;
Lyall, S;
... Collinge, J; + view all
(2014)
Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked.
Nat Commun
, 5
, Article 4347. 10.1038/ncomms5347.
|
Sarell, CJ;
Quarterman, E;
Yip, DC-M;
Terry, C;
Nicoll, AJ;
Wadsworth, JDF;
Farrow, MA;
... Collinge, J; + view all
(2017)
Soluble A beta aggregates can inhibit prion propagation.
Open Biology
, 7
(11)
, Article 170158. 10.1098/rsob.170158.
|
Sarell, CJ;
Quarterman, E;
Yip, DC-M;
Terry, C;
Nicoll, AJ;
Wadsworth, JDF;
Farrow, MA;
... Collinge, J; + view all
(2017)
Soluble Aβ aggregates can inhibit prion propagation.
Open Biology
, 7
(11)
, Article 170158. 10.1098/rsob.170158.
|
Sawyer, EB;
Edgeworth, JA;
Thomas, C;
Collinge, J;
Jackson, GS;
(2015)
Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease.
Scientific Reports
, 5
, Article 17742. 10.1038/srep17742.
|
Schmidt, C;
Fizet, J;
Properzi, F;
Batchelor, M;
Sandberg, MK;
Edgeworth, JA;
Afran, L;
... Collinge, J; + view all
(2015)
A systematic investigation of production of synthetic prions from recombinant prion protein.
Open Biology
, 5
(12)
, Article 150165. 10.1098/rsob.150165.
|
Schott, JM;
Crutch, SJ;
Carrasquillo, MM;
Uphill, J;
Shakespeare, TJ;
Ryan, NS;
Yong, KX;
... Mead, S; + view all
(2016)
Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1016/j.jalz.2016.01.010.
|
Sequeira, Danielle;
Nihat, Akin;
Mok, Tzehow;
Coysh, Thomas;
Rudge, Peter;
Collinge, John;
Mead, Simon;
(2022)
Prevalence and Treatments of Movement Disorders in Prion Diseases: A Longitudinal Cohort Study.
Movement Disorders
10.1002/mds.29152.
(In press).
|
Sims, R;
van der Lee, SJ;
Naj, AC;
Bellenguez, C;
Badarinarayan, N;
Jakobsdottir, J;
Kunkle, BW;
... Schellenberg, GD; + view all
(2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease.
Nature Genetics
, 49
pp. 1373-1384.
10.1038/ng.3916.
|
Smethurst, P;
Risse, E;
Tyzack, GE;
Mitchell, JS;
Taha, DM;
Chen, Y-R;
Newcombe, J;
... Patani, R; + view all
(2020)
Distinct responses of neurons and astrocytes to TDP-43 proteinopathy in amyotrophic lateral sclerosis.
Brain
, 143
(2)
pp. 430-440.
10.1093/brain/awz419.
|
Swarup, V;
Hinz, FI;
Rexach, JE;
Noguchi, K-I;
Toyoshiba, H;
Oda, A;
Hirai, K;
... Geschwind, DH; + view all
(2019)
Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.
Nature Medicine
, 25
(1)
pp. 152-164.
10.1038/s41591-018-0223-3.
|
Taskesen, E;
Mishra, A;
Van Der Sluis, S;
Ferrari, R;
Veldink, JH;
Van Es, MA;
Smit, AB;
... Pijnenburg, Y; + view all
(2017)
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS.
Scientific Reports
, 7
, Article 8899. 10.1038/s41598-017-09320-z.
|
Tattum, MH;
Jones, S;
Pal, S;
Collinge, J;
Jackson, GS;
(2010)
Discrimination between prion-infected and normal blood samples by protein misfolding cyclic amplification.
Transfusion
, 50
(5)
996 - 1002.
10.1111/j.1537-2995.2010.02595.x.
|
Tattum, MH;
Jones, S;
Pal, S;
Khalili-Shirazi, A;
Collinge, J;
Jackson, GS;
(2010)
A highly sensitive immunoassay for the detection of prion-infected material in whole human blood without the use of proteinase K.
Transfusion
, 50
(12)
2619 - 2627.
10.1111/j.1537-2995.2010.02731.x.
|
Terry, C;
Harniman, RL;
Sells, J;
Wenborn, A;
Joiner, S;
Saibil, HR;
Miles, MJ;
... Wadsworth, JDF; + view all
(2019)
Structural features distinguishing infectious ex vivo mammalian prions from non-infectious fibrillar assemblies generated in vitro.
Scientific Reports
, 9
, Article 376. 10.1038/s41598-018-36700-w.
|
Terry, C;
Wenborn, A;
Gros, N;
Sells, J;
Joiner, S;
Hosszu, LL;
Tattum, MH;
... Wadsworth, JD; + view all
(2016)
Ex vivo mammalian prions are formed of paired double helical prion protein fibrils.
Open Biology
, 6
(5)
10.1098/rsob.160035.
|
Thomas, DX;
Bajaj, S;
McRae-McKee, K;
Hadjichrysanthou, C;
Anderson, RM;
Collinge, J;
(2020)
Association ofTDP‑43
proteinopathy, cerebral
amyloid angiopathy, and Lewy
bodies with cognitive
impairment in individuals
with or withoutAlzheimer’s disease
neuropathology.
Scientific Reports
, 10
(1)
, Article 14579. 10.1038/s41598-020-71305-2.
|
Thompson, AG;
Uphill, J;
Lowe, J;
Porter, MC;
Lukic, A;
Carswell, C;
Rudge, P;
... Mead, S; + view all
(2015)
Genome-wide association study of behavioural and psychiatric features in human prion disease.
Transl Psychiatry
, 5
, Article e552. 10.1038/tp.2015.42.
|
Thompson, AGB;
Anastasiadis, P;
Druyeh, R;
Whitworth, I;
Nayak, A;
Nihat, A;
Mok, TH;
... Mead, S; + view all
(2021)
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
Molecular Psychiatry
10.1038/s41380-021-01045-w.
(In press).
|
Thompson, AGB;
Luk, C;
Heslegrave, AJ;
Zetterberg, H;
Mead, SH;
Collinge, J;
Jackson, GS;
(2018)
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(9)
pp. 955-961.
10.1136/jnnp-2017-317793.
|
Trevitt, CR;
Hosszu, LL;
Batchelor, M;
Panico, S;
Terry, C;
Nicoll, AJ;
Risse, E;
... Clarke, AR; + view all
(2014)
N-terminal domain of prion protein directs its oligomeric association.
J Biol Chem
, 289
(37)
25497 - 25508.
10.1074/jbc.M114.566588.
|
van der Lee, SJ;
Conway, OJ;
Jansen, I;
Carrasquillo, MM;
Kleineidam, L;
van den Akker, E;
Hernández, I;
... Holstege, H; + view all
(2020)
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
[Corrigendum].
Acta Neuropathologica
10.1007/s00401-019-02107-8.
(In press).
|
Wadsworth, JDF;
Adamson, G;
Joiner, S;
Brock, L;
Powell, C;
Linehan, JM;
Beck, JA;
... Collinge, J; + view all
(2017)
Methods for Molecular Diagnosis of Human Prion Disease.
Methods in Molecular Biology: Prions
, 1658
pp. 311-346.
10.1007/978-1-4939-7244-9_22.
|
Wadsworth, JDF;
Joiner, S;
Linehan, JM;
Jack, K;
Al-Doujaily, H;
Costa, H;
Ingold, T;
... Collinge, J; + view all
(2021)
Humanised transgenic mice are resistant to chronic wasting disease prions from Norwegian reindeer and moose.
The Journal of Infectious Diseases
10.1093/infdis/jiab033.
(In press).
|
Wenborn, A;
Terry, C;
Gros, N;
Joiner, S;
D'Castro, L;
Panico, S;
Sells, J;
... Wadsworth, JD; + view all
(2015)
A novel and rapid method for obtaining high titre intact prion strains from mammalian brain.
Scientific Reports
, 5
, Article 10062. 10.1038/srep10062.
|
Whitfield, JT;
Pako, WH;
Collinge, J;
Alpers, MP;
(2017)
Cultural factors that affected the spatial and temporal epidemiology of kuru.
ROYAL SOCIETY OPEN SCIENCE
, 4
, Article 160789. 10.1098/rsos.160789.
|
Zhang, D;
Qi, Y;
Klyubin, I;
Ondrejcak, T;
Sarell, CJ;
Cuello, AC;
Collinge, J;
(2017)
Targeting glutamatergic and cellular prion protein mechanisms of amyloid β-mediated persistent synaptic plasticity disruption: longitudinal studies.
Neuropharmacology
, 121
pp. 231-246.
10.1016/j.neuropharm.2017.03.036.
|
Zhang, M;
Ferrari, R;
Tartaglia, MC;
Keith, J;
Surace, EI;
Wolf, U;
Sato, C;
... International FTD-Genomics Consortium (IFGC), .; + view all
(2018)
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.
Brain
, 141
(10)
pp. 2895-2907.
10.1093/brain/awy238.
|
Thesis
Begum, R;
(2013)
Functional analysis of Hectd2: a prion disease modifier associated with incubation time.
Doctoral thesis , UCL (University College London).
|
Reilly, Madeleine Louise;
(2019)
Development of an in vitro assay of prion-induced neurotoxicity.
Doctoral thesis (Ph.D), UCL (University College London).
|
Thomas, David Mark Xavier;
(2019)
Investigating the biochemical signature and in vivo seeding activity of amyloid-β from distinct Alzheimer’s Disease subtypes.
Doctoral thesis (Ph.D), UCL (University College London).
|